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ABSTRACT: Atomistic molecular dynamics (MD) and steered MD
simulations in combination with umbrella sampling methodology were
utilized to study the general anesthetic propofol and the opioid analgesic
fentanyl and their interaction with lipid bilayers, which is not yet fully
understood. These molecules were inserted into two different fully hydrated
phospholipid bilayers, namely, dioleoylphosphatidylcholine (DOPC) and
dipalmitoylphosphatidylcholine (DPPC), to investigate the effects that these
drugs have on the bilayer. We determined the role of the lipid chain length
and saturation on the behavior of the two drugs. Pure, fully hydrated DOPC
and DPPC bilayers were also simulated, and the results were in excellent
agreement with the experimental values. Various structural and mechanical
properties of each system, such as the area per lipid, area compressibility
modulus, order parameter, lateral lipid diffusion, hydrogen bonds, and radial
distribution functions, have been calculated to assess how the drug molecules affect the different bilayers. From the calculated results,
we show that fentanyl and propofol generally follow similar trends in each bilayer but adopt different favorable positions close to the
headgroup/chain interface at the carbonyl groups. Propofol was shown to selectively form hydrogen bonds at the carbonyl carbon in
each bilayer, whereas fentanyl interacts with water molecules at the headgroup interface. From the calculated free-energy profiles, we
determined that both molecules show a preference for the low-density, low-order acyl chain region of the bilayers and both
significantly preferred the DOPC bilayer with propofol and fentanyl having energy minima at −6.66 and −43.07 kcal mol−1,
respectively. This study suggests that different chain lengths and levels of saturation directly affect the properties of these two
important molecules, which are seen to work together to control anesthesia in surgical applications.
1. INTRODUCTION
An important stage of the mechanism of action of any drug
molecule is the diffusion through cellular membranes. The
favored positions of these drug molecules within the target
membranes also affect their transport and metabolism.1 The
most important membrane encountered by drug molecules is
the plasma membrane into which these pharmaceuticals
penetrate and with which they interact to reach the target
cells.2 The major components within these plasma membranes
are the phosphatidylcholine (PC) lipids,3 which are hence
most commonly used in the modeling of drug interactions with
cell membranes. Knowledge of the interactions between drug
molecules and lipids is clearly essential to improve their
mechanism of action and efficiency.
In this study, we have studied two drug molecules embedded
in two different PC bilayers, namely, dipalmitoylphosphati-
dylcholine (DPPC) and dioleoylphosphatidylcholine (DOPC),
which are displayed in Figure 1c,d, respectively. Both lipids
consist of a zwitterionic headgroup region with a positively
charged choline group and a negatively charged phosphate
group. The difference between the lipids lies in the different
lengths and saturation of the linear chains, (i.e., 16, fully
saturated for DPPC and 18, unsaturated for DOPC).
Since its introduction, propofol has been used routinely in
general surgery as a general anesthetic to induce and maintain
anesthesia. Propofol is also commonly used alongside opioid
analgesics such as fentanyl. The use of these opioid analgesics
has been shown to potentiate propofol,4 thereby reducing the
amount of drug required to induce anesthesia, which in turn
reduces the unwanted side effects of propofol anesthesia, e.g., a
large drop in blood pressure5 and apnea.6 Propofol is proposed
to interact and bind at the γ-aminobutyric acid (GABA)
receptors,7 consisting of ligand-gated ion channels (GABAA)
and G protein-coupled receptors (GABAB), which both
control the flow of ions into the intracellular domain. There
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have also been studies that suggest that propofol acts at G
protein-coupled receptors by inhibiting the function of M1
muscarinic acetylcholine receptors.8 These studies suggest
possible binding sites of propofol, but a complete mechanism
for the action of anesthesia still remains unknown. Due to its
properties, fentanyl is used in general surgery as the analgesic
component to general anesthesia and also as the lone
component.9 Various studies have shown that when used in
combination with propofol, it provides a safer and more
satisfactory anesthesia method.10−12 Fentanyl is known to act
at various opioid sites throughout the body but predominately
at the μ-receptor, although it also binds to δ-type and κ opioid
receptors.13 Although the binding sites for opioid drugs are
relatively well known, it still remains unclear why fentanyl is
able to potentiate propofol during anesthesia. Our previous
work showed that fentanyl also modulates the Gloebacter
violaceus ion channel, which is a known site for general
anesthetic action.14
Propofol, as shown in Figure 1a, consists of a benzene ring
core with two isopropyl groups at the 2 and 6 positions and
one hydroxyl group in between. The hydroxyl group is
reasonably well guarded by the steric bulk of the isopropyl
groups, so hydrogen bonding will only be available in certain
orientations. The structure of fentanyl, shown in Figure 1b,
differs significantly from propofol. Fentanyl has an almost
linear, flexible backbone consisting of two aromatic and one
aliphatic six-membered rings and an acetyl group bonded to
the terminal nitrogen.
To provide atomistic insight into the interaction of these
drug molecules with the cellular membrane, molecular
dynamics (MD) simulations have been used to investigate
the thermodynamics and structural changes that these drug
molecules induce on the lipid bilayer. Despite the enormous
growth of the field of biomolecular simulation in recent
years,15 to the best of our knowledge, no studies have been
reported, which directly compare, in a single study, these two
drug molecules interacting with phospholipid membranes.
Therefore, the primary aim of this paper is to investigate how
these drug molecules behave within the bilayer systems by
characterizing how the anesthetics alter the structural proper-
ties of the membranes themselves. In addition, we have also
calculated the free-energy profile of diffusion of each drug
molecule through each bilayer system, using the biased MD
umbrella sampling method.
2. RESULTS AND DISCUSSION
2.1. Area per Lipid. The area per lipid is considered to be
one of the most important properties to describe the behavior
of the bilayer and whether it is in the correct, biologically
relevant Lα phase. This area can be calculated easily from our
MD trajectories. The calculation involves dividing the xy cross-
sectional area of the orthorhombic periodic cell (i.e., the lateral
area of the bilayer) by the number of lipids.16 The areas per
lipid calculated for each pure bilayer simulation are shown in
Table 1. The results obtained were within around 3−4% of the
experimental values from the literature, which suggests that our
simulated pure bilayers are in the correct phase and have
equilibrated sufficiently to be used for the drug molecule
simulations. The results for bilayers containing propofol are
also shown in Table 1. Here, we see an increase in the area per
lipid when propofol is simulated in the center of each bilayer
(0.25 Å in DOPC and 0.27 Å in DPPC) due to the drug
molecule interacting in the upper chain region around the
carbonyl groups at the headgroup−chain interface. When
propofol was simulated in the water phase, we observed natural
diffusion into both types of lipid bilayers, leading to a larger
Figure 1. Molecular structures of (a) propofol, (b) fentanyl, (c)
dipalmitoylphosphatidylcholine, and (d) dioleoylphosphatidylcholine.
The first and second carbons of the glycerol fragment are denoted as
the sn-1 and sn-2 positions, respectively.
Table 1. Averaged Structural Properties of Pure and Drug-Containing Lipid Bilayer Systems, Where Area per Lipid = (AL),
Volume per Lipid = (VL), Isothermal Area Compressibility Modulus = (KA), Bilayer Thickness = (DHH), and Lateral Lipid
Diffusion Coefficient = (Dxy)
a
lipid drug AL (Å
2) VL (Å
3) KA (m Nm
−1) DHH (Å) Dxy (10
−8 cm2 s−1)
DOPC experimental none 67.4, 72.517 130318 265, 31818 35.3, 37.117 11.5, 1719
DOPC calculated none 70.1 ± 0.2 1274.2 ± 1.1 285.2 ± 19.7 37 ± 0.2 6.30
DPPC experimental none 63.1, 64.320 123218 23121 38, 38.317 12.5, 15.222
DPPC calculated none 62.9 ± 0.3 1175 ± 0.2 231.9 ± 22.7 37.8 ± 0.2 8.8
DOPC propofol center 70.3 ± 0.3 1275 ± 1.5 419.5 ± 15.6 36.25 ± 1.1 12.75
propofol water 70.94 ± 0.2 1279.7 ± 1.0 333 ± 30.1 36.75 ± 0.5 11.25
fentanyl center 70.33 ± 0.2 1261.7 ± 1.3 227.6 ± 16.0 36.5 ± 1.0 7.9
fentanyl water 70.2 ± 0.4 1262.3 ± 1.3 274 ± 20.5 37.25 ± 0.2 6.4
DPPC propofol center 63.17 ± 0.4 1176.8 ± 1.5 319.5 ± 22.7 37 ± 0.7 17.5
propofol water 63.50 ± 0.5 1177.8 ± 0.9 243.1 ± 16.0 37.25 ± 0.9 14
fentanyl center 63.58 ± 0.4 1179 ± 1.1 236.2 ± 25.0 37.5 ± 0.8 8.3
fentanyl water 62.86 ± 0.6 1179 ± 1.0 331.2 ± 13.0 37.25 ± 0.70 6.4
aWater and center refer to the starting positions of the drug molecule.
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increase in area due to disruption in the headgroup regions.
This expansion of AL can be rationalized in terms of the lone-
pair repulsions as propofol diffuses through the headgroup
region. A similar pattern is observed when fentanyl is in the
center of the bilayer as we observe further increases in the area,
especially for DPPC. Our simulations of DPPC indicate that
fentanyl does not lie as close to the headgroup region as
propofol does but rather lies parallel and slightly below the
carbonyl groups. We only observed spontaneous diffusion into
the DOPC system for fentanyl, which caused a small 0.1 Å
increase in the area per lipid. This observation can be explained
by fentanyl diffusing in a linear conformation, which causes less
disruption, whereas propofol is much more dynamic in its
diffusion process, adopting more conformations. The calcu-
lated volume per lipid followed the same trend as the area per
lipid as they are directly proportional.
2.2. Isothermal Area Compressibility Modulus. The
isothermal area compressibility modulus (KA) is the stress
required to induce an isotropic expansion in volume, which can
be calculated from MD simulations as
σ
= ⟨ ⟩K k T A
n
2
A
B L
lipid A
2
(1)
where kB is Boltzmann’s constant, T is the simulation
temperature, ⟨AL⟩ is the average area per lipid, σA
2 is the
variance in the area per lipid over the simulation, and nlipid is
the number of lipids in the simulation box. KA is a standard
descriptor of the membrane phase, with large values being
characteristic of the Lβ gel phase, as the chains would be fully
extended and their van der Waals interactions would
strengthen and lead to tighter, more ordered lipid packing.
Our results for the KA of the pure bilayers are in excellent
agreement with the experimentally obtained values. When
propofol starts in a position in the center of either membrane
and diffuses toward the carbonyl region, we found an increase
in KA, which induces a closer packing of the lipid chains. The
conformational changes of the membrane chains increase the
aforementioned interactions between them, causing the bilayer
to stiffen (see Figures 4 and 13). The largest increase in KA is
observed for DOPC, owing to the presence of the double bond
in the chain, in which the drug molecule inhibits the fluidity by
binding in the upper chain region. During the diffusion process
from the water phase into the membrane, we observe a small
increase in KA due to the fast diffusion through the headgroup
region. This observation suggests that the process of stiffening
is not instantaneous, and the direction of diffusion plays a key
role. In the DOPC bilayer, we calculate a lower KA for fentanyl
compared to that for propofol, which indicates that fentanyl is
causing more fluctuation within the headgroup region of the
bilayer (see Figure 2). For the natural diffusion of fentanyl into
the DOPC bilayer, we observe that KA decreases by a small
amount (11.2 m Nm−1) compared to that of the pure
membrane, which shows that the diffusion does not allow the
chains to pack particularly tightly together. For fentanyl in the
DPPC bilayer, we calculate a small 4.3 m Nm−1 increase
compared to that of the pure membrane, even though the drug
molecule positions itself parallel to the headgroups at the
interface, as it does in DOPC. As such, the difference in the
chain structure plays a significant role in the way that the
structural properties of lipid bilayers are affected by drug
molecules. The most unexpected result found for fentanyl is
the simulation with the drug molecule in the water phase
where we saw no diffusion, even though the resulting KA shows
an increase of 99.3 m Nm−1 over the pure bilayer. This result is
interesting because fentanyl has no direct contact with the lipid
chains and spends most of its time during the simulation at the
water−headgroup interface. During the course of the
simulation, we observe several partial diffusions, where fentanyl
enters the headgroup region for 1−4 ns before returning into
the water phase. These partial diffusions suggest that fentanyl
induces a conformational change in the headgroups, which
allows the chains to pack closer together and stiffen the bilayer.
To confirm whether there was a change in the conformation of
the headgroup environment when fentanyl partially diffuses
into the headgroup region of the DPPC bilayer, the angles
between the P−N vector and the normal of the bilayer were
calculated using the MEMBPLUGIN tool23 for VMD.24 For
the pure DPPC bilayer, an angle of 69.0 ± 2.4° was calculated,
which is almost identical in the fentanyl-containing system. To
study the specific conformation of the headgroups, which
fentanyl causes disruptions when it partially diffuses, head-
group molecules were selected, which were 15 Å from the
fentanyl molecule. The P−N vectors were calculated as 73.0 ±
2.0°, which shows that fentanyl causes a conformational
change with the headgroup region. Results for propofol are not
shown as there was no change in the P−N vector due to the
Figure 2. Starting positions for fentanyl (A) and propofol (B) in the bilayers. End positions after the production simulation of fentanyl (C) and
propofol (D); DOPCs shown as positions were similar in both systems. Headgroups are shown as yellow sticks, headgroup phosphate is shown as
an orange sphere, and lipid chains are shown as gray sticks.
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fast diffusion through the headgroup region into the membrane
interior.
2.3. Lipid Lateral Diffusion. The lateral diffusion of a
lipid bilayer is an important dynamical property, as it can affect
many membrane parameters. For example, one study reported
a connection between the lateral lipid diffusion and the
viscosities in different parts of the membrane.25 In this work,
we have calculated the lateral diffusion coefficient of the lipids
without (for reference) and with the drug molecules, using the
mean-squared displacement (MSD) of the membrane, in the
xy direction, over 20 ns window lengths and averaged over
time origins separated by 200 ps (Figure 3). This property is
related to the Einstein equation in two dimensions
= ⟨|Δ | ⟩
→∞
D
t
r tlim
1
4
d
d
( )
t
2
(2)
where ⟨|Δr(t)|2⟩ is the MSD in the XY plane in time t, and D
represents the lateral diffusion coefficient. The diffusion
coefficient can be obtained from the gradient of the linear
portion of the MSD plot. Table 1 lists the calculated lateral
diffusion coefficients for pure DOPC and DPPC, which are
comparable to those calculated in the Lipid14 paper.26 Our
production runs were performed in the NPT ensemble using
Langevin dynamics to control the temperature, which
randomizes particle velocities and can therefore affect dynamic
membrane properties such as lateral diffusion. Slightly more
accurate results can be obtained using the microcanonical
(NVE) ensemble, which was applied in the original lipid14
publication.26 However, as our results for the pure bilayers
were within the experimentally determined values, we decided
to continue the drug molecule simulations in the NPT
ensemble. With the addition of propofol within the bilayer, we
observe a slight increase in the lateral diffusion coefficient for
both lipid systems (Table 1). This finding is unexpected since
the drug molecules can penetrate the lipid bilayer where they
occupy a portion of the free volume within the membrane and
reduce the lateral diffusion.27 This hypothesis is indeed
observed when we have a spontaneous diffusion of propofol
from the water phase as it occupies the free volume space
within the headgroup region, whereas propofol starting within
the bilayer does not penetrate fully into the headgroup space.
For fentanyl, we observe a significant decrease in the lateral
diffusion constant in both systems with respect to propofol.
This difference in behavior can be explained by the larger size
of the fentanyl molecule compared to that of propofol, which
therefore occupies more free volume within the bilayer, hence
limiting the fluidity of the membrane.
2.4. Lipid Tail Order Parameters. The hydrocarbon tails
that make up the hydrophobic interior of the bilayer are highly
dynamic, which accounts for the overall fluidity of the
membrane.28 The mobility of these chains at individual carbon
positions can be evaluated by measuring the order parameter.
A value of SCD = 1 implies a position parallel to the bilayer
normal, and a value of SCD = 0 implies total random motion.
Experimentally, this property is determined by using deuterium
NMR quadrupole splitting, which entails substituting the
hydrogen atoms at each carbon position with deuterium and
measuring their dynamic variations by 2H NMR. A detailed
description of the procedure can be found here.29 This
property can also be calculated from our simulations, where
the carbon−deuterium order parameter is determined by the
tensor S in the equation
θ= ⟨ − ⟩S 1
2
3cos 12
(3)
where θ represents the angle formed between the Z direction
and the bilayer normal. Simulated results for the pure bilayers
are shown in Figure 4, with comparison to literature values.
Our results obtained for the pure bilayer simulations are in
good agreement with the trends observed experimentally.
Figure 5 shows the results obtained for the bilayers containing
the drug molecules. For the DOPC sn-1 chain, we observe very
little change when the drug molecules are present compared to
the pure bilayer. A very small increase is observed between
carbons 3 and 6, with respect to the pure bilayer, which
suggests a slightly restricted motion of the chains at this
position due to the presence of the two drug molecules. A
small decrease in the order parameter for fentanyl between
carbons 10 and 11 suggests more mobility at these positions.
Figure 3. Time-averaged mean-squared displacement of the lipid
center of mass (COM) versus simulation time.
Figure 4. SCD order parameters for (a) DOPC and (b) DPPC compared to experiment.
30−32
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This behavior is also seen in the sn-2 chain for both anesthetic
molecules, although note the lower values in carbons 12−14,
which could account for the reduced area compressibility
calculated for fentanyl due to the chains becoming more
flexible and hence requiring less force to induce an isotropic
expansion.
In the DPPC system, we see clearer differences between the
drug-loaded bilayers compared to that between the pure
bilayer reference. In the sn-1 chain, we observe that propofol
increases the order parameter from carbons 5 to 12, reducing
the chain mobility and hence requiring more force to induce an
isotropic expansion within the bilayer, in agreement with KA.
The introduction of fentanyl causes only a negligible change in
the order parameter of the pure DPPC bilayer. The sn-2 chain
shows a clear difference in the 6−13 region compared to the
pure membrane. Propofol causes a higher-order parameter for
these carbons, as seen in the sn-2 chain, whereas fentanyl
shows lower values at this point, which would suggest a more
flexible chain and hence a lower KA. Table 1 shows that there is
no correlation between the lipid chain mobility and KA, which
indicates that the flexibility in the headgroup region could be
the link between them. We should note here that a similar
study conducted on the local anesthetic articaine in a DMPC
bilayer found higher-order parameter values for the neutral
form of the molecule, similar to propofol in the DPPC
bilayer.33 The differences observed in that study are larger,
which is most likely due to the higher concentration of drug
molecules used in the simulations.
2.5. Hydrogen Bonds. Hydrogen bonds were observed
between the drug molecules and water, and propofol was also
observed to form hydrogen bonds with the headgroups of both
lipid systems. The conditions used to determine if a hydrogen
bond was formed were set by a bond distance of 2.5 Å between
the donor hydrogen and the acceptor atom with a maximum
angle of 30° between the donor hydrogen and acceptor
hydrogen vectors.34 Figure 6a shows that the pattern of
hydrogen bonding to water is similar in both bilayer systems.
Hydrogen bonds were mostly formed between the hydrogen of
the propofol hydroxyl group and the oxygen of the water
molecules. A few times during the simulations, the
conformation allowed the hydrogen from another water
molecule to coordinate with the propofol hydroxyl oxygen.
The average number of hydrogen bonds formed per frame was
similar for DOPC (0.120) and DPPC (0.119). Figure 6b
shows the hydrogen-bonding pattern for fentanyl in both
bilayers. Hydrogen bonds are formed faster within the DPPC
bilayer as this is the most fluid membrane (Table 1, Dxy),
which allows the drug molecule to move faster toward the
interface with water and hence form hydrogen bonds. Fentanyl
has two extra possible hydrogen-bonding sites, i.e., carbonyl
oxygen and both nitrogens, compared to propofol that has only
one (hydroxyl oxygen) site, which explains the different
number of hydrogen bonds formed. Fentanyl forms bonds
between both the carbonyl oxygen and the neighboring
nitrogen to water hydrogen. No bonds are formed to the
Figure 5. SCD order parameters for (a) DOPC sn-1 chain, (b) DOPC sn-2 chain, (c) DPPC sn-1 chain, and (d) DPPC sn-2 chain. Order
parameters for drug-containing systems calculated when the drug was present in the hydrophobic phase of the bilayer.
Figure 6. Hydrogen-bond plots of (a) propofol-to-water, (b) fentanyl-
to-water, and (c) propofol-to-lipid headgroups; and (d) snapshot of
fentanyl binding to water within the hydrophobic phase. Hydrogen-
bond distance is shown in panel in Angstroms (d).
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piperidine nitrogen due to steric hindrance and the
conformation adopted by fentanyl. Again, we calculate very
similar hydrogen bonds in each bilayer, i.e., 0.758 and 0.715 for
DOPC and DPPC, respectively. From Figure 6c, we can see
that propofol forms hydrogen bonds to the lipid headgroups in
both DOPC and DPPC, which fentanyl is unable to do. The
carbonyl oxygen of the sn-1 chain is favored in both lipids over
the sn-2, due to the conformation that the headgroup adopts
throughout the simulations, which makes it better accessible
for bonding. Figure 6d shows a snapshot from the simulation
of DOPC, where we noted a number of water molecules
entering the hydrophobic phase and forming “anchoring”
hydrogen bonds to fentanyl. This behavior was observed in
both bilayers but to a greater extent in the DOPC membrane.
This phenomenon was not seen with propofol, which could
account for its higher mobility within the bilayer compared to
that of fentanyl. Table 2 shows the average number of
hydrogen bonds per frame between lipid headgroups and water
molecules, which is used as a means to assess the effect of the
drug molecules on the ability of the headgroups to form
hydrogen bonds to the surrounding media. In the DPPC
bilayer containing either of the two drug molecules, we observe
very little change in the number of hydrogen bonds between
the headgroups and water compared to the pure bilayer. The
results for the DOPC system show a clear increase in the
number of hydrogen bonds formed in the presence of fentanyl.
This observation can be explained by the disruptions caused by
fentanyl in the headgroup region (Figure 7), which can
accommodate more water molecules at the interface, thereby
increasing the potential for hydrogen bonding. These results
highlight the different behavior observed in the two different
PC lipid bilayers despite their close structural similarity.
2.6. Radial Distribution Function. To gain further
insight into the distribution of water and the drug molecules
around the bilayer, we have carried out radial distribution
function (RDF) analyses. Figure 8 shows the RDF plots for the
oxygen atom of water around the phosphorous of the
headgroup. From the insets of each graph, we can see that
when fentanyl is added to the membrane there is a higher
density of water molecules around the phosphate group. This
difference is slightly larger in the DOPC system, which agrees
with the observations that fentanyl causes more water
molecules to penetrate into the headgroup region. RDFs
were also computed for the atoms in each drug molecule,
which exhibited hydrogen bonding to water and, in the case of
propofol, the lipid headgroup. Figure 9a displays that water is
more concentrated around the carbonyl oxygen of fentanyl in
DOPC, with an average hydrogen-bond distance to water of
1.75 Å. The peak for the oxygen-to-oxygen density is a further
1 Å away, which indicates the length of the O−H bond in the
water molecule. Figure 9b shows the same trend for DPPC as
for DOPC, although the densities for N to H and N to O are
closer, with the O-to-O density slightly higher by 0.05. Figure
9c shows the dominance of hydrogen bonding between
propofol and the headgroup region. The conformation of the
headgroup in DOPC increases the sn-1 lipid chain in such a
way that it is better accessible to form hydrogen bonds to
propofol. We found a higher density for sn-1 and sn-2 in
DPPC due to the differences in chain mobility between the
two systems; see Figure 9d. A sharp shoulder peak is observed
at 1.95 Å in the propofol DPPC system, which is due to
hydrogen bonds forming at slightly different distances.
Table 2. Number of Hydrogen Bonds Formed between
Lipid Headgroups and Water
lipid drug average bond per frame
DOPC none 464.880
fentanyl 481.300
propofol 467.752
DPPC none 396.409
fentanyl 397.453
propofol 399.372
Figure 7. Multiple water molecules moving through the DOPC lipid headgroup into the hydrophobic phase of the bilayer. Lipid headgroup is
shown as yellow sticks, lipid tails are shown as gray sticks, phosphorous atom of the phosphate group is shown as an orange sphere, water molecules
within 5 Å of fentanyl are shown as blue spheres, and fentanyl is shown as sticks.
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2.7. Clinical Concentration Simulations. By conducting
these simulations at clinical concentrations, we can observe
how these drug molecules perturb the membrane structure in a
way that we cannot observe in the single-molecule simulations.
Initially, the molecules were added to the water phase outside
of the membrane, and over the course of the simulations, they
diffuse into the membrane interior. Figure 10 shows the final
positions of the drugs within the membrane, which were very
similar in DOPC and DPPC, so only one is shown. The
average positions of the drug molecules over the course of the
simulations can be calculated with decomposed electron
density profiles computed using CPPTRAJ.35 These profiles
(Figure 11) were constructed for each drug molecule in each
bilayer using an average over all replicates. Both drug
molecules are located predominantly under the lipid head-
groups in the membrane interior. This observation is
consistent with other molecules that possess anesthetic
properties, such as alcohols,36 benzocaine,37 and halothane.38
The two drug molecules prefer slightly different depths within
the bilayers, with propofol having a density maximum at
approximately 10.3 Å from the bilayer center in both DOPC
and DPPC, while fentanyl has a density maximum at
Figure 8. Radial distribution function plots of (a) water oxygen to phosphorous of DOPC and (b) DPPC lipid bilayers. The insets show the
increase in density caused by the addition of the drug molecules.
Figure 9. Radial distribution function plots of (a) fentanyl hydrogen-bonding atoms to water hydrogen and oxygen in DOPC; (b) fentanyl
hydrogen-bonding atoms to water hydrogen and oxygen in DPPC; (c) propofol hydroxyl hydrogen to water hydrogen and oxygen, and sn-1 and sn-
2 carbonyl oxygen in DOPC; and (d) propofol hydroxyl hydrogen to water hydrogen and oxygen, and sn-1 and sn-2 carbonyl oxygen in DPPC.
Figure 10. End states of propofol (left) and fentanyl (right) in the lipid bilayers. Phosphorous atoms are shown as orange spheres, lipid headgroups
are shown as yellow sticks, lipid tails are shown as gray sticks, and drug molecules are shown as VdW spheres.
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approximately 9.1 Å in DPPC and approximately 10.3 Å in
DOPC. The density for fentanyl in both bilayers is higher than
that for propofol in the center (0 Å), which indicates that the
fentanyl molecules are able to cross the bilayer on the time
scale of the simulation, as the free energy is lower in the center
for fentanyl (Figure 16).
To gain further insight into the hydration state and
coordination of the drug molecules and the probability
distribution of the water molecules around the drugs and the
lipid headgroups, RDFs of the water oxygen around the
phosphate of the lipid headgroup have been calculated for both
drug molecules in both lipid bilayers, as shown in Figure 12.
The RDF plots for the water oxygen around the phosphate
group show similar behavior for both lipid systems, with the
first minimum indicating the hydrogen bond between water
and the phosphate oxygen. The RDFs for the systems
containing the drug molecules are considerably higher, which
can be understood from the density plots, which show that
both drug molecules are mostly located in the upper part of the
lipid tails and the ester group area. The presence of the drug
molecules creates a larger area per lipid in all systems (Table
3), which allows more space in the headgroup region that can
be filled with additional water molecules, thereby increasing
the hydration at the headgroup/extracellular region.
To assess how these drug molecules at clinical concentration
alter the membrane ordering and dynamics, we have calculated
headgroup tilt angles, SCD order parameters (Figure 13), and
lipid lateral diffusions (Table 3). Order parameter plots show
little or no changes when single drug molecules were
incorporated into the bilayers (Figure 5), but when clinical
concentrations are used, we observe more significant changes
in the membrane dynamics. The tilt angle of a phospholipid
headgroup is an important property because of the dipole
moment associated with the zwitterionic headgroup, which is
involved in long-range electrostatics, which can affect many of
the bilayer properties.39 Drug molecules, which are located in
or close to the headgroup region, may cause disruption of this
angle, which was observed for lidocaine40 and articaine.33
Table 4 shows the average calculated angles between the P−N
headgroup vector and the bilayer normal for two pure
reference systems and the systems containing clinical
concentrations of the drug molecules. Results are obtained
using the MEMBPLUGIN tool23 for VMD. For these
calculations, all lipids were included as opposed to lipids
located close to each drug molecule due to the higher number
of drug molecules in the systems. The data presented in Table
4 show small influences from the drug molecules, more so for
propofol due to the increased number of molecules in the
system compared to fentanyl. Results for single-molecule
simulations were identical to those for the pure systems, so
they are not shown here. More significant results were
obtained for the previously mentioned lidocaine and articaine
as these molecules are charged, which caused a decrease in the
angle by around 20° due to the charged molecules located
within the lipid headgroup area, so the positive charge on these
molecules causes a repulsion of the choline groups outwards
toward the water phase. Both propofol and fentanyl in our
simulations are neutral, and they therefore reside in the upper
chain region near the ester group and slightly deeper toward
the membrane center for fentanyl (Figure 11), so there is no
charge−charge interactions to significantly alter the P−N
vector. The increased hydration of the headgroups (Figure 12)
can therefore be explained by the drug molecules causing
separation in the headgroup region, which is seen as an
increase in the area per lipid, shown in Table 3, which allows
water molecules to penetrate deeper into the headgroup region
where hydrogen bonds are formed to the drug molecules.
The calculated order parameters (Figure 13) show that these
drugs at clinical concentrations have a significant impact on the
dynamics of the lipid chains. For DOPC-containing propofol,
we calculate an increase in KA, which suggests a rigid/stiff
bilayer, an increase in thickness, and a decrease in lipid lateral
diffusion. The SCD plot shows a higher-order parameter in the
upper chain region for propofol, more apparent in the sn-1
chain, resulting from the propofol occupying this space, which
reduces the density of lipid tails here, causing them to
straighten. Similar results are seen for fentanyl, in which KA
and DHH also increase but to a smaller extent compared to
those for propofol. The diffusion calculated for fentanyl in
DOPC is almost identical to that of the pure system, which
suggests that the number of molecules present in the system is
a crucial factor in lipid lateral diffusion. The SCD order
parameters for carbons 9 and 10 in both DOPC systems show
a significant decrease; these carbons form the double bond in
the DOPC lipid chain, which is a region where the drug
Figure 11. Total and decomposed electron density plots for propofol
in DOPC (A) and DPPC (B), and fentanyl in DOPC (C) and DPPC
(D). Contributions from water, choline, phosphate (PO4), glycerol
(Gly), carbonyl (COO), methylene (CH2), unsaturated CH = CH,
and terminal methyls (CH3).
Figure 12. Radial distribution functions of water oxygen around the
phosphate of the DOPC and DPPC lipid molecules in the pure
system (black), propofol system (red), and fentanyl system (blue).
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molecules do not spend any notable time. We suggest that this
decrease in order is due to the positioning of the drugs near the
ester groups, which disrupts the conventional packing of the
lipid chains. For the DPPC systems, we see similar trends in
KA, DHH, and Dxy compared to the DOPC systems. The upper
region of the carbon chains in which propofol resides has an
increased order parameter, which suggests stiffening of that
region, as seen in the KA value and lower diffusion coefficients.
For fentanyl, we see lower-order parameters for carbon 6
onwards in both the sn-1 and sn-2 chains, suggesting higher-
chain mobility in this region, but this is not what we see in the
diffusion coefficients, which show a decrease in membrane
fluidity.
2.8. Potentials of Mean Force. The potential of mean
force (PMF) is an important part of the overall membrane
permeability, which can be obtained from
∫ β= = [ ]R P
W z
D z
z
1 exp ( )
( )
d
z
z
1
2
(4)
where R is the resistivity, P represents the permeability, β is the
thermodynamic β (β = 1/kBT), W(z) is the PMF, D(z) is the
local diffusivity coefficient, and z is the variable, which
describes the position of the solute along the transmembrane
axis. The PMFs were calculated by pulling the drug molecule
from the center of the membrane into the water phase, which
has been shown by Filipe et al.41 to give faster convergence of
the PMF compared to pulling from the water phase into the
membrane. The PMFs were then symmetrized, i.e., the profiles
were adjusted to be identical on either side of the bilayer
center and both start and end at 0.42 Our chosen method of
computing the PMFs for our systems was the Umbrella
sampling.43 This approach involves applying a harmonic
potential between the center of mass (COM) of the drug
molecule and the bilayer, with a harmonic force constant of 2.5
kcal mol−1 rad2. Figure 14 shows the PMF profiles for propofol
in DPPC and DOPC. We can see that there is a large
difference of 5.54 kcal mol−1 between the free energy at z = 0
in both bilayers. The negative PMF values for both bilayers
Table 3. Averaged Structural Properties of Pure and Clinical Concentration Systems, Where Area per Lipid = (AL), Volume
per Lipid = (VL), Isothermal Area Compressibility Modulus = (KA), Bilayer Thickness = (DHH), and Lateral Lipid Diffusion
Coefficient = (Dxy)
system AL (Å
2) VL (Å
3) KA (m Nm
−1) DHH (Å) Dxy (10
−8 cm2 s−1)
DOPC pure 70.1 ± 0.2 1274.2 ± 1.1 285.2 ± 19.7 37 ± 0.2 6.3
DPPC pure 62.9 ± 0.3 1175 ± 0.2 231.9 ± 22.7 37.8 ± 0.2 8.8
DOPC propofol 76.8 ± 0.4 1363.8 ± 2.3 666.7 ± 31.0 37.4 ± 0.3 5.8
DOPC fentanyl 71.0 ± 0.3 1283.4 ± 1.6 394.7 ± 15.9 37.25 ± 0.2 6.4
DPPC propofol 70.3 ± 0.4 1280 ± 0.9 312.1 ± 26.0 37.7 ± 0.4 6
DPPC fentanyl 66.0 ± 0.2 1242.2 ± 1.4 256.2 ± 14.0 37.6 ± 0.3 6.4
Figure 13. SCD order parameters for DOPC (top) and DPPC (bottom) containing clinical concentrations of propofol and fentanyl.
Table 4. Average DOPC and DPPC Angles between the P−
N Vector and the Normal of the Bilayers for Pure and Drug-
Containing Systems
system P−N vector angle (deg) standard error (±)
pure DOPC 68.88 2.30
propofol DOPC 70.60 2.31
fentanyl DOPC 70.14 2.30
pure DPPC 69.00 2.4
propofol DPPC 71.1 2.0
fentanyl DPPC 70.02 2.4
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indicate that z = 0 is a favorable position for propofol, which is
not surprising as this molecule possesses a lone ionizable
hydroxyl group with a pKa of 11,
44 while the remaining
structural components are highly lipophilic. This high
lipophilicity gives a poor water miscibility (150 μg L−1) and
a log P value of 4.16.45 As such, we would expect that propofol
would be very stable within the hydrophobic, low-density, and
low-order acyl chain region. A small dip in the minimum is
observed at z = ±1.0 Å in the DOPC system, where the PMF
drops to −6.66 kcal mol−1. A similar but more pronounced
pattern is seen in the DPPC system, where the PMF drops to a
minimum of −1.47 kcal mol−1 at 2 Å further away than in
DOPC. This difference of 5.19 kcal mol−1 between the minima
of the two systems occurs because propofol is closer to the
high-density acyl chain region. We found that the higher order
in DPPC is caused by the shorter chain length and full
saturation, which allows closer packing of the chains. Propofol
prefers to reside close to carbon 13 in DPPC and carbon 17 in
DOPC at the PMF minima, which explains their energy
difference. As propofol traverses toward the water phase, we
observe a steep increase in free energy until it enters the water
phase at 18 Å where the free energy is set to 0. For DPPC, we
do observe a slight increase in free energy within the
headgroup region to a maximum of 0.06 kcal mol−1. This is
not unusual due to the highly structured nature of the
headgroup region, characterized by strong specific interactions
that restrict their motion, which can hinder the diffusion of
hydrophobic solutes.46 To investigate this behavior further, we
have plotted in Figure 15 the z-dependent diffusion coefficient
profile. From the diffusion profile, we can see the decrease in
diffusion within the DPPC system at, and close to, the
headgroup region compared to that of DOPC, which accounts
for the increase in energy observed compared to that obtained
for DOPC. Figure 14 shows a small barrier at 10 Å in the
DPPC bilayer, which is most likely due to the excess hydration
of the drug molecule, which is overcome as the drug penetrates
deeper into the membrane interior; we can see this reflected in
Figure 15, where propofol has diffusion coefficient slightly
higher than in DOPC. These results show that the difference in
chain length and saturation can significantly alter the drug
diffusion, suggesting that propofol will be more selective
toward the longer and unsaturated part of the cellular
membrane.
Figure 16 depicts a trend similar to the lower PMF in the
DOPC system for fentanyl compared to that for propofol. The
minimum energy occurs when fentanyl is at z = 0.0 Å with a
PMF of −43.07 kcal mol−1. In the DPPC system, the minimum
occurs at z = ±2.0 Å but at 35 kcal mol−1 higher than in
DOPC. This result is again expected because fentanyl is a large
hydrophobic and lipophilic molecule. We can rationalize the
difference in the PMF due to fentanyl’s close proximity to the
high-density and less mobile acyl chain region in DPPC. In
both lipids, we observe a linear increase in the PMF as fentanyl
Figure 14. Potential of mean force profile for propofol in DOPC and DPPC bilayers (left), and a histogram showing the suitable overlapping of
windows (right).
Figure 15. Propofol z-dependent diffusion profile in DOPC and
DPPC.
Figure 16. Potential of mean force profile for fentanyl in DOPC and
DPPC bilayers.
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traverses from the membrane center into the water phase,
where the PMF is defined as 0. Unlike propofol, we do not
observe the increase in PMF within the headgroup region for
fentanyl in the DPPC system, owing to the linear conformation
adopted by fentanyl when it diffuses through the headgroups,
as observed in our nonbiased simulations. Figure 17 shows the
z-dependent diffusion profile for fentanyl in both bilayers. Our
umbrella sampling simulations indicate that fentanyl has a
significantly lower diffusion and mobility over the range
around 20 Å, leading to a higher PMF. However, the free
energy is much lower in DOPC, because fentanyl adopts a
more favorable conformation within this less ordered environ-
ment. As fentanyl moves into the water phase, we see a large
increase in diffusion, which almost reaches the same values as it
does in the DPPC bilayer. The diffusion profile of the
molecules shows the greatest variance between propofol and
fentanyl in this study. We should note here that the center of
the bilayers are theoretically the most stable region for both
drug molecules, as indicated by the PMF plots, but we have to
remember that these simulations are carried out with harmonic
restraints in each window. In the unrestrained simulations for
single drug molecules and clinical concentrations, the drugs do
not reside at the bilayer center during the simulations (Figure
11) but are mostly located at the upper chain region/
headgroup interface due to the highly dynamic nature of the
lipid chains.
3. CONCLUSIONS
In this study, we have utilized fully atomistic molecular
dynamics simulations to model the physical and mechanical
properties of pure and drug-containing lipid bilayers. Propofol
and fentanyl show similar trends in the way they alter the
general properties of both DOPC and DPPC. We determined
that propofol prefers to form hydrogen bonds with the
carbonyl oxygens of the lipid headgroups, especially with the
sn-1 chain in both model membranes. Fentanyl prefers to
orient itself parallel to the headgroups at the interface, where it
forms hydrogen bonds with water, which are made available as
a result of the disruption caused in the headgroup region due
to the presence and positioning of fentanyl. Hydrogen-bonding
analysis showed an increase in water molecules within the
headgroups, most noticeably in the DOPC membrane. The
calculated radial distribution functions also showed a higher
density of water molecules around the phosphate group when
fentanyl was present and to a lesser extent for propofol. Biased
MD simulations in combination with umbrella sampling
methodology were used to obtain the PMF and z-dependent
diffusion profiles for both drug molecules in each lipid bilayer
system. Our PMF and z-dependent diffusion profiles highlight
the effects of chain length and level of saturation within the
bilayer and how this could affect the selectivity for different
parts of the cellular membrane by each drug. Our simulations
involving the clinical concentrations of propofol and fentanyl
show in detail that these drugs can cause significant
perturbations to the membrane structure. At these concen-
trations, both drugs were shown to cause increased hydration
of the lipid headgroups, stiffening of the acyl chains, and hence
a decrease in the membrane fluidity. The resulting structural
defects from our simulations could provide the basis for
investigations into the indirect modulation of membrane
protein function by both of these drugs, which are the main
components of total intravenous anesthesia.
4. METHODOLOGY
4.1. Structure Generation. The initial structures of both
lipid bilayers were constructed using the CHARMM-GUI
Membrane Builder47 at the experimentally observed hydration
levels48,49 of 32.8 and 30.1 water molecules per lipid for DOPC
and DPPC, respectively. Sixty-four lipid molecules were placed
in each leaflet to form bilayers consisting of 128 lipids. The
PDB files were converted into the lipid14 forcefield format,
with the charmmlipid2amber.py script implemented into the
Amber simulation package.50 Structures for propofol and
fentanyl were generated using Avogadro51 and geometry
optimized using the Amber-GAFF forcefield52 with the
steepest decent method. Atom types, bond types, and atomic
partial charges were assigned using the AM1-BCC semi-
empirical quantum mechanical method53 implemented into
the antechamber program in Amber.54 In total, 14 systems
were simulated, including two pure bilayer systems to generate
equilibrated structures for use with the drug molecules and to
reference our computational setup via comparison with
experimental results. Four DOPC and DPPC systems were
simulated, where each single molecule was placed individually
inside either the bilayer hydrophobic phase or the water phase.
Four additional simulations were carried out at clinical
concentrations, where the drug molecules were added
randomly to the water phase. The concentrations used for
propofol and fentanyl were 7.155 and 1.0 μM,56 which
corresponds to approximately 36 and 4 molecules, respectively.
4.2. Simulation Details. All MD simulations in this study
were carried out using the Amber16 simulation package,54 with
the lipid14,26 ff14SB,57 and GAFF52 forcefields. The TIP3P
water model58 was used to describe the water molecules. More
in-depth details of the general simulation procedure used can
be found in the original lipid14 paper.26 All production
simulations were carried out in the isothermal−isobaric (NPT)
ensemble, which maintains a constant number of particles,
pressure, and temperature. The temperatures were maintained
at the lipid-relevant temperature of 303 K for DOPC and 323
K for DPPC to be consistent with the experiment, using the
Langevin thermostat59 with a collision frequency of γ = 1.0
ps−1. The pressure was maintained at 1 atm using the
anisotropic Berendsen method,60 with a pressure relaxation
time of 1.0 ps. Three-dimensional periodic boundary
conditions with the usual minimum image convention were
used. The SHAKE algorithm61 was used to constrain covalent
bonds to hydrogen, allowing the use of a 2 fs time step.
Electrostatic interactions were treated with the PME method
Figure 17. Fentanyl z-dependent diffusion profile in DOPC and
DPPC.
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using a cutoff of 10 Å. The pure bilayer simulations were run
for a total of 125 ns, with the first 25 ns discarded from the
final analysis. Simulations containing the drug molecules were
run from the equilibrated pure bilayer structure for a total of
100 ns each after a short 5 ns equilibration in which the drug
molecules were harmonically restrained to allow equilibration
of the solvent or bilayer. The biased MD umbrella sampling
simulations were run using the GPU version of Amber16.62,63
The drug molecule was pulled from the center of the bilayer
into the water phase along the z-axis by steered molecular
dynamics (SMD), for a total of 27 Å with a pulling rate of 1 Å
per ns. The force constant for pulling was set at 1.1 kcal mol−1
rad2, and the force constant for restraint was set at 2.5 kcal
mol−1 rad2 for the window simulations. From the SMD
simulations, 27 windows were extracted (1 Å apart) along the
z-axis from the center of the bilayer to the water phase. Each
window was further simulated for 50 ns. The potential of mean
force (PMF) profile was constructed using the weighted
histogram analysis method (WHAM).64 The analysis in this
study was performed using the CPPTRAJ35 program
implemented into the AmberTools1654 package, with visual-
ization through tools supplied in VMD.24 For simulations
containing drug molecules, the 5 ns equilibration phase was
not included in the analysis. In the single drug molecule
simulations, lipids in the leaflet, where the drug molecule
interacts, were used for the analysis of lipid properties; in the
clinical concentration simulations, all lipids were used.
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(2) Paloncyóva,́ M.; Berka, K.; Otyepka, M. Convergence of free
energy profile of coumarin in lipid bilayer. J. Chem. Theory Comput.
2012, 8, 1200−1211.
(3) Simons, K.; Toomre, D. Lipid rafts and signal transduction. Nat.
Rev. Mol. Cell Biol. 2000, 1, 31.
(4) Vuyk, M. Pharmacokinetic and pharmacodynamic interactions
between opioids and propofol. J. Clin. Anesth. 1997, 9, 23S−26S.
(5) Robinson, B. J.; Ebert, T.; O’brien, T.; Colinco, M.; Muzi, M.
Mechanisms whereby Propofol Mediates Peripheral Vasolidation in
Humans Sympathoinhibition or Direct Vascular Relaxation. Anes-
thesiology 1997, 86, 64−72.
(6) Langley, M. S.; Heel, R. C. Propofol. Drugs 1988, 35, 334−372.
(7) Trapani, G.; Altomare, C.; Sanna, E.; Biggio, G.; Liso, G.
Propofol in anesthesia Mechanism of action, structure-activity
relationships, and drug delivery. Curr. Med. Chem. 2000, 7, 249−271.
(8) Nagase, Y.; Kaibara, M.; Uezono, Y.; Izumi, F.; Sumikawa, K.;
Taniyama, K. Propofol inhibits muscarinic acetylcholine receptor-
mediated signal transduction in Xenopus oocytes expressing the rat
M1 receptor. Jpn. J. Pharmacol. 2001, 79, 319−325.
(9) Stanley, T. H. The fentanyl story. J. Pain 2014, 15, 1215−1226.
(10) Phillips, A. S.; McMurray, T.; Mirakhur, R.; Gibson, F.; Elliott,
P. Propofol-fentanyl anesthesia: a comparison with isoflurane-fentanyl
anesthesia in coronary artery bypass grafting and valve replacement
surgery. J. Cardiothorac. Vasc. Anesth. 1994, 8, 289−296.
(11) Bajwa, S. J. S.; Bajwa, S. K.; Kaur, J. Comparison of two drug
combinations in total intravenous anesthesia: Propofol-ketamine and
propofol-fentanyl. Saudi J. Anaesth. 2010, 4, 72.
(12) Petersen, K. D.; Landsfeldt, U.; Cold, G. E.; Petersen, C. B.;
Mau, S.; Hauerberg, J.; Holst, P.; Olsen, K. S. Intracranial Pressure
and Cerebral Hemodynamic in Patients with Cerebral TumorsA
Randomized Prospective Study of Patients Subjected to Craniotomy
in Propofol-Fentanyl, Isoflurane-Fentanyl, or Sevoflurane-Fentanyl
Anesthesia. Anesthesiology 2003, 98, 329−336.
(13) Chen, J.-C.; Smith, E. R.; Cahill, M.; Cohen, R.; Fishman, J. B.
The opioid receptor binding of dezocine, morphine, fentanyl,
butorphanol and nalbuphine. Life Sci. 1993, 52, 389−396.
(14) Faulkner, C.; Plant, D. F.; de Leeuw, N. H. Modulation of the
Gloeobacter violaceus Ion Channel by Fentanyl: A Molecular Dynamics
Study Biochemistry 2019, 58, 4804 4808 DOI: 10.1021/acs.bio-
chem.9b00881.
(15) Dror, R. O.; Dirks, R. M.; Grossman, J.; Xu, H.; Shaw, D. E.
Biomolecular simulation: a computational microscope for molecular
biology. Annu. Rev. Biophys. 2012, 41, 429−452.
(16) Skjevik, A.; Madej, B. D.; Walker, R. C.; Teigen, K. LIPID11: a
modular framework for lipid simulations using amber. J. Phys. Chem. B
2012, 116, 11124−11136.
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